孤立结节型浸润性黏液腺癌的影像诊断:形态-代谢分离征的应用
本研究回顾性分析35例孤立结节型浸润性黏液腺癌(IMA)与329例浸润性非黏液腺癌,评估CT与PET/CT的形态-代谢分离征(M-M分离征)的鉴别效能。M-M分离征在IMA中占54%、非黏液腺癌中占10%(p<0.001),其诊断IMA的敏感度54.3%、特异度89.7%、阳性预测值35.8%、阴性预测值94.9%。结论认为,识别M-M分离征的缺失是排除IMA的准确指标。
要点
- M-M分离征定义为CT上恶性形态(分叶或毛刺、肿瘤阴影消失率<0.5)但PET/CT SUVmax<3.5。
- 该征在IMA中占54%(19/35),在非黏液腺癌中占10%(34/329),差异有统计学意义(p<0.001)。
- 该征阴性(即无M-M分离征)时排除IMA的阴性预测值为94.9%(95%CI 92.8-96.4)。
核心结论
- 识别M-M分离征的缺失是排除孤立结节型肺腺癌中IMA的准确指标。
研究设计与样本
- 回顾性研究,纳入手术切除的孤立结节型肺腺癌(直径<3 cm)患者,IMA 35例、浸润性非黏液腺癌329例,采用CT和PET/CT评估M-M分离征。
关键影像表现/征象
- M-M分离征表现为CT上呈恶性形态(分叶或毛刺、肿瘤阴影消失率<0.5)而PET/CT SUVmax<3.5。
- IMA组SUVmax为1.8±2.0,浸润性非黏液腺癌组SUVmax为4.6±4.2。
- IMA组肿瘤大小为21±7 mm,浸润性非黏液腺癌组为21±6 mm。
诊断标准与关键数值
- M-M分离征诊断IMA的敏感度为54.3%(95%CI 36.7-71.2),特异度为89.7%(95%CI 85.9-92.7)。
- M-M分离征诊断IMA的阳性预测值为35.8%(95%CI 26.5-46.5),阴性预测值为94.9%(95%CI 92.8-96.4)。
- 多因素分析显示代谢良性(OR 2.99;95%CI 1.01-8.93;p=0.047)和M-M分离征(OR 6.35;95%CI 2.76-14.62;p<0.001)是孤立结节型IMA的显著预测因素。
临床应用与阅片要点
- 阅片时对CT上呈分叶或毛刺、肿瘤阴影消失率<0.5但PET/CT SUVmax<3.5的结节,应提示M-M分离征可能。
- M-M分离征阴性时对排除IMA的阴性预测值达94.9%,可辅助鉴别诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the efficacy of the morphologic-metabolic (M-M) dissociation sign based on computed tomography (CT) and fluorine-18-fluorodeoxyglucose positron emission tomography (PET)/CT in discriminating invasive mucinous adenocarcinoma (IMA) from invasive non-mucinous adenocarcinomas (ADCs) of the lung.
MATERIALS AND METHODS: The Institutional Review Board approved this retrospective study. Among surgically resected solitary pulmonary nodule (SPN)-type ADCs (< 3 cm in diameter), 35 patients with IMAs and 329 with invasive non-mucinous ADCs were included. Morphologic malignancy was established if the tumor with lobulated or spiculated margin on CT presented a tumor shadow disappearance rate of < 0.5. The M-M dissociation sign was determined when a malignant-morphologic nodule on CT showed maximum standardized uptake value (SUVmax) < 3.5 on PET/CT.
RESULTS: Among 35 IMAs (size: 21 ± 7 mm, SUVmax: 1.8 ± 2.0) and 329 invasive non-mucinous ADCs (size: 21 ± 6 mm, SUVmax: 4.6 ± 4.2), the M-M dissociation sign was observed in 54% of IMAs (19/35) and 10% of invasive non-mucinous ADCs (34/329) (p < 0.001). The diagnostic performance of the sign in discriminating IMA from invasive non-mucinous ADCs showed a sensitivity of 54.3% (95% confidence interval [CI], 36.7-71.2), specificity 89.7% (95% CI, 85.9-92.7), positive predictive value 35.8% (95% CI, 26.5-46.5), and negative predictive value 94.9% (95% CI, 92.8-96.4). Multivariate analyses revealed metabolic benignity (odds ratio [OR] 2.99; 95% CI, 1.01-8.93; p = 0.047) and M-M dissociation sign (OR 6.35; 95% CI, 2.76-14.62; p < 0.001) to be significant predictors of SPN-type IMAs.
CONCLUSION: Identification of the absence of M-M dissociation sign is an accurate indicator for excluding IMA from SPN-type lung ADCs.
引用
- Cha MJ, Lee KS, Kim TJ, et al. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign. Korean J Radiol. 2019. PMID: 30799583. doi:10.3348/kjr.2018.0409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。